Novartis Korea increases distribution margins under collection condition

While some multinational pharmaceutical companies are in confrontation with the pharmaceutical distribution industry due to low margins, Novartis Korea has increased distribution margins.

According to the distribution industry, Novartis Korea has sent official documents containing contents about the ‘distribution margin modification case,’ such as ‘Basic Condition Modification: After this mont...